New shot aims to stop chemo side effect in cancer patients

NCT ID NCT06521931

First seen Mar 11, 2026 · Last updated May 15, 2026 · Updated 10 times

Summary

This early-stage trial tested a new drug called PN20 in 24 adults with lymphoma or solid tumors who had low platelets from chemotherapy. The goal was to see if a single shot before chemo is safe and could help prevent dangerously low platelet counts. Researchers monitored patients closely for 21 days after each dose.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THROMBOCYTOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Affiliated Hospital of Hebei University

    Baoding, Hebei, 071000, China

  • Affiliated Hospital of Southwest Medical University

    Luzhou, Sichuan, 646000, China

  • Henan Cancer Hospital

    Zhengzhou, Henan, 450008, China

  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong, 266057, China

  • The First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, 471003, China

  • Yiyang Central Hospital

    Yiyang, Hunan, 413099, China

Conditions

Explore the condition pages connected to this study.